LAURANTIS PHARMA
Laurantis Pharma Oy is a specialty pharmaceutical development company with a broad, clinical-stage portfolio in three therapeutic areas: dermatology, ophthalmology, and oncology. Using two proprietary technologies, Laurantis is developing first-in-class products for commercially and medically significant niche indications in these areas. Laurantis was formed in December 2010 through a merger of the Finnish drug development companies Oy Lx Therapies Ltd and BioCis Pharma Oy.
LAURANTIS PHARMA
Social Links:
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2003-01-01
Address:
Turku, Western Finland, Finland
Country:
Finland
Website Url:
http://www.laurantis.com
Total Employee:
1+
Status:
Active
Contact:
358 2478 8378
Email Addresses:
[email protected]
Total Funding:
5.64 M EUR
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail IPv6 Hetzner Sendgrid
Similar Organizations
Exponential Biotherapies
Exponential Biotherapies develops therapeutics to attenuate overreactions of the immune system.
Khonsu Therapeutics
Developing therapeutic proteins for autoimmune & inflammatory indications in human & animal health
Current Advisors List
Current Employees Featured
Founder
Investors List
Inveni Capital
Inveni Capital investment in Venture Round - Laurantis Pharma
Broadview Ventures
Broadview Ventures investment in Venture Round - Laurantis Pharma
Official Site Inspections
http://www.laurantis.com
- Host name: fi-p1.seravo.net
- IP address: 95.217.73.56
- Location: Finland
- Latitude: 60.1717
- Longitude: 24.9349
- Timezone: Europe/Helsinki
More informations about "Laurantis Pharma"
Home » Laurentis Energy Partners
Welcome to Laurentis Energy Partners, a company dedicated to excellence in every aspect of nuclear energy and the industries it supports. With its in-depth knowledge of the nuclear sector …See details»
About Laurentis » Laurentis Energy Partners
As a commercial subsidiary of Ontario Power Generation – one of North America’s largest and most diverse clean-energy generators and innovators – Laurentis brings unparalleled real-world experience and technical expertise to …See details»
Laurentis Energy Partners to produce Y-90 isotopes for …
Mar 7, 2024 · TORONTO, ON – Cancer patients in Canada and around the world will receive treatment using Yttrium-90 (Y-90) isotopes produced by Laurentis Energy Partners (Laurentis) and harvested from Ontario Power Generation ’s …See details»
Laurentis Energy Partners - LinkedIn
Laurentis Energy Partners, a wholly-owned commercial subsidiary of Ontario Power Generation that was formerly known as Canadian Nuclear Partners, is an innovator and leader in the …See details»
Laurentis Energy Partners to produce Y-90 isotopes for …
TORONTO, March 7, 2024 /CNW/ - Cancer patients in Canada and around the world will receive treatment using Yttrium-90 (Y-90) isotopes produced by Laurentis Energy Partners (Laurentis) and...See details»
Laurentis Energy Partners to produce Y-90 isotopes for life-saving ...
Mar 7, 2024 · Laurentis will use its proprietary Target Delivery System (TDS), developed in partnership with BWXT Medical, to produce Y-90. Pending regulatory approvals, Laurentis …See details»
BioCis Pharma, Lx Therapies Combine to Create Laurantis
May 26, 2011 · BioCis Pharma Oy and Oy Lx Therapies Ltd. announced today that the companies have combined to create Laurantis Pharma Oy (“Laurantis Pharma”), a clinical-stage specialty …See details»
Laurantis Pharma - VentureRadar
Laurantis is a clinical-stage specialty pharmaceutical development company formed through the merger of two independent companies, BioCis Pharma Oy and Oy Lx Therapies Ltd in late …See details»
Senior leadership team » Laurentis Energy Partners
Meet the people who are implementing Laurentis’s plan for strategic growth and leadership in the fields of nuclear energy services and isotope production. Jason Van Wart joined Laurentis Energy Partners in 2018 as Vice President. In …See details»
Laurantis Pharma - Crunchbase Company Profile & Funding
Sep 4, 2012 · Laurantis Pharma Oy is a specialty pharmaceutical development company with a broad, clinical-stage portfolio in three therapeutic areas: dermatology, ophthalmology, and …See details»
Laurantis Pharma - Contacts, Employees, Board Members
Laurantis Pharma develops therapeutics for medical niche indications in the dermatology, ophthalmology, and oncology sectors.See details»
Laurantis Pharma - Crunchbase
Laurantis Pharma develops therapeutics for medical niche indications in the dermatology, ophthalmology, and oncology sectors.See details»
Laurantis Pharma Company Profile 2024: Valuation, Investors ...
Information on acquisition, funding, cap tables, investors, and executives for Laurantis Pharma.See details»
Products » Laurentis Energy Partners
Laurentis’s product line includes radioisotopes for both medical and non-medical applications as well as specialized nuclear energy-related equipment. On this page, explore Laurentis’s …See details»
BioCis Pharma and Oy Lx Therapies become Laurantis
Jun 2, 2011 · Finland-based BioCis Pharma and Oy Lx Therapies have combined to create Laurantis Pharma, a developer of clinical-stage specialist pharmaceuticals. The new company …See details»
Laurantis Pharma - Products, Competitors, Financials, Employees ...
Laurantis Pharma is a clinical stage biotechnology company that develops formulations and applications of cis-urocanic acid, a locally acting anti-inflammatory and anti-proliferative agent …See details»
Laurantis Pharma Completes Funding Round for Research Program
Sep 4, 2012 · First human trial of Lymfactin, investigational treatment for breast cancer-associated Lymphedema, receives funding from Broadview Ventures.See details»
Board of Directors » Laurentis Energy Partners
As a wholly owned subsidiary of Ontario Power Generation (OPG), Laurentis’s Board is made up of senior OPG leaders whose vision and depth of knowledge helps set the strategic direction …See details»
Lurantis Pokédex: stats, moves, evolution & locations
Lurantis is a Grass type Pokémon introduced in Generation 7. Lurantis draws opponents near to itself with its flowerlike appearance and aroma—and then it takes them down. It’s said to be …See details»
Nuclear lifecycle services » Laurentis Energy Partners
Jul 18, 2024 · Laurentis has the experience and expertise to help clients along the entire lifecycle of a nuclear reactor, from inspections and maintenance, to complete refurbishment, all the way …See details»